Genprex, Inc. (GNPX) short interest & options flow
NASDAQShort sellers have built one of the most extreme positions in the micro-cap biotech universe heading into GNPX's Q1 results today, and the borrow market confirms the pressure isn't easing. Short interest has more than doubled in a month — up 117% — to reach 73.8% of the free float, an extraordinary level for any stock at any size. The lending market underscores how aggressive this…
GNPX short interest plunges 22.8% in one week to 59.4% of float; cost to borrow eases to 17.4%.
- Market cap
- $2M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026
Latest signals on GNPX
- Short Interest
GNPX short interest plunges 22.8% in one week to 59.4% of float; cost to borrow eases to 17.4%.
GNPX news and analysis
RSSNo long-form analysis yet for GNPX. Pulse alerts and the live data picture are available on ORTEX.
Open GNPX on ORTEX →Want the live picture for GNPX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GNPX — free to start on ORTEX.
Sign up for free →Open GNPX on ORTEX